𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P91 Gemcitabine, epirubicin, and docetaxel (GED) asneoadjuvant therapy. Updated results from a multicenter phase II trial in locally advanced breast cancer

✍ Scribed by D. Yardley; P. Whitworth; F. Greco; L. Dunbar; H. Burris; M. White; M. Melodie; K. Yost; J. Hainsworth

Book ID
114315814
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
160 KB
Volume
14
Category
Article
ISSN
0960-9776

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

P-463 Preliminary results of a multicent
P-463 Preliminary results of a multicenter randomized phase II trial oftwo different combinations of docetaxel (D) and gemcitabine (G) and of cisplatin/gemcitabine (CG) followed by docetaxel as first line therapy for locally advanced or metastatic non small cell lung cancer (NSCLC)
✍ Bernardini, I.; Rinaldi, M.; CrinΓ², L.; Nardi, M.; De Marinis, F.; Tonato, M.; S πŸ“‚ Article πŸ“… 2005 πŸ› Elsevier Science 🌐 English βš– 130 KB